OBJECTIVE: Several studies have suggested that higher serum uric acid levels lead to a lower risk of Parkinson's disease (PD) because uric acid exerts antioxidant effects on neurons. Our objective was to examine the relationship between gout and the risk of PD in persons age > or = 65 years. METHODS: We conducted a population-based cohort study using the British Columbia Linked Health Database and PharmaCare data (i.e., prescription drug data for those age > or = 65 years). We compared incidence rates of PD between 11,258 gout patients and 56,199 controls matched on age, sex, date of gout diagnosis, and length of medical record. Cox proportional hazards models were used to estimate the relative risk (RR) of PD, adjusting for age, sex, prior comorbid conditions, and use of diuretics and nonsteroidal antiinflammatory drugs. RESULTS: Over an 8-year median followup, we identified 1,182 new cases of PD. Compared with individuals without gout, the multivariate RR of PD among those with gout was 0.70 (95% confidence interval [95% CI] 0.59-0.83). In subgroup analyses, the inverse association was similarly present in both sexes and was evident among those who did not use diuretics (RR 0.66, 95% CI 0.54-0.81), but not among diuretic users (RR 0.80, 95% CI 0.58-1.10, P for interaction 0.35). CONCLUSION: Our population-based data provide evidence for a protective effect of gout on the risk of PD and support the purported protective role of uric acid.
OBJECTIVE: Several studies have suggested that higher serum uric acid levels lead to a lower risk of Parkinson's disease (PD) because uric acid exerts antioxidant effects on neurons. Our objective was to examine the relationship between gout and the risk of PD in persons age > or = 65 years. METHODS: We conducted a population-based cohort study using the British Columbia Linked Health Database and PharmaCare data (i.e., prescription drug data for those age > or = 65 years). We compared incidence rates of PD between 11,258 goutpatients and 56,199 controls matched on age, sex, date of gout diagnosis, and length of medical record. Cox proportional hazards models were used to estimate the relative risk (RR) of PD, adjusting for age, sex, prior comorbid conditions, and use of diuretics and nonsteroidal antiinflammatory drugs. RESULTS: Over an 8-year median followup, we identified 1,182 new cases of PD. Compared with individuals without gout, the multivariate RR of PD among those with gout was 0.70 (95% confidence interval [95% CI] 0.59-0.83). In subgroup analyses, the inverse association was similarly present in both sexes and was evident among those who did not use diuretics (RR 0.66, 95% CI 0.54-0.81), but not among diuretic users (RR 0.80, 95% CI 0.58-1.10, P for interaction 0.35). CONCLUSION: Our population-based data provide evidence for a protective effect of gout on the risk of PD and support the purported protective role of uric acid.
Authors: Eilis J O'Reilly; Xiang Gao; Marc G Weisskopf; Honglei Chen; Michael A Schwarzschild; Donna Spiegelman; Alberto Ascherio Journal: Am J Epidemiol Date: 2010-08-02 Impact factor: 4.897
Authors: Przemyslaw Swiatkowski; Emily Sewell; Eric S Sweet; Samantha Dickson; Rachel A Swanson; Sara A McEwan; Nicholas Cuccolo; Mark E McDonnell; Mihir V Patel; Nevin Varghese; Barclay Morrison; Allen B Reitz; David F Meaney; Bonnie L Firestein Journal: Neurobiol Dis Date: 2018-07-19 Impact factor: 5.996
Authors: Alberto Ascherio; Peter A LeWitt; Kui Xu; Shirley Eberly; Arthur Watts; Wayne R Matson; Connie Marras; Karl Kieburtz; Alice Rudolph; Mikhail B Bogdanov; Steven R Schwid; Marsha Tennis; Caroline M Tanner; M Flint Beal; Anthony E Lang; David Oakes; Stanley Fahn; Ira Shoulson; Michael A Schwarzschild Journal: Arch Neurol Date: 2009-12
Authors: Kristin S Biggerstaff; Donna L White; Benjamin J Frankfort; Peter Richardson; Silvia Orengo-Nania; Jose Garcia; Elizabeth Y Chiao; Jennifer R Kramer Journal: Graefes Arch Clin Exp Ophthalmol Date: 2021-07-17 Impact factor: 3.117